Autonomic Cardiovascular Control After Heart Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this prospective study is to investigate denervation (ie. surgical cutting of autonomic nerves) and re-innervation (ie. growth of autonomic nerves) in heart transplant recipients. More specifically, we focus on:

1. The physiological consequences of denervation, in particular its consequences for clinical symptoms, orthostatic tolerance (ie. the ability to stand upright) and exercise capacity. We hypothesize that denervation has negative consequences for all these factors.
2. The pathological consequences of denervation and reinnervation, in particular its association to acute rejection and coronary artery disease (cardiac allograft vasculopathy, CAV). We hypothesize that reinnervation protects against acute rejection and development of CAV
3. Donor and recipient factors associated with the reinnervation process. We hypothesize that characteristics of the surgical procedure (such as aorta cross-clamp time) as well as the rehabilitation process of the recipient (such as physical activity) impacts on the reinnervation process.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)

NCT05895669

Liver Transplant; Complications Cardiovascular Complication Cardiovascular; Attack +2 more

UNKNOWN

Clinical Observational Study Investigating the Role of Diastolic Dysfunction in Determining Abnormal Cardiorespiratory Exercise Testing Parameters in Patients Undergoing Major Surgery

NCT00765349

Diastolic Dysfunction

UNKNOWN

Acute Cardiac Dysfunction in Critical Illnes

NCT05860504

Multi Organ Failure Left Ventricular Dysfunction Right Ventricular Dysfunction +3 more

RECRUITING

Cardiac Transplant Metabolomics With and Without Rejection

NCT05772442

Heart Transplant Rejection

NOT_YET_RECRUITING

Lymphatic Morphology of Fontan Patients

NCT04163653

Lymphatic Abnormality Plastic Bronchitis Protein-Losing Enteropathies +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Heart transplantation is annually offered to more than 3500 patients worldwide. In Norway, the number is approximately 30/year, and all transplants are carried out at one single hospital (Oslo University Hospital, Rikshospitalet).

Normally, the heart function is intimately controlled by the autonomic nervous system (ANS), but all nervous connections are lost during the surgical transplantation procedure, and the transplanted heart thus becomes denervated. In time, regrowth of nerves may cause partial reinnervation of the new heart.

Some evidence suggests that reinnervation improves exercise capacity and reduces episodes of acute rejections and the development of cardiac allograft vasculopathy. The purpose of this study is further to investigate the changes over time with respect to all parts of the autonomic nervous system (the sympathetic, parasympathetic and sensoric part), and the associated physiological and pathological consequences.

The study may provide knowledge which ultimately could help us improve health and quality of live for heart transplant recipients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Transplant Recipients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Heart transplant recipients

Patients receiving orthotopic heart transplant in the enrollment period

No interventions assigned to this group

Healthy controls

Healthy control subjects, having the same age and sex distribution as the heart transplant recipients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Completed heart transplantation during the last 7-12 weeks
* Age \> 16 years and \< 70 years

\- Age and gender matching the HTRs

Exclusion Criteria

* Peri- or postoperative complications causing permanent dysfunction of the allograft (such as hyperacute rejection episodes, severe myocardial ischemia, etc.)
* Diabetes with HbA1C \> 6,5 % and/or manifest diabetic complications
* Renal failure with plasma creatinine \> 200 µmol/L
* ECG abnormalities (scattered ectopic beats ad minor conduction problems are allowed)
* Permanently bed-ridden

* Another chronic disease (such as diabetes mellitus)
* Permanent use of pharmaceuticals (including hormone drugs)
* Pregnancy

Minimum Eligible Age

17 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes